For Purchasing Managers, Technical Directors & Operations Leaders who need reliable, cost‑effective API supply for hormone‑therapy drugs.
Get Free Quote in 24 hIn 2026, corporate purchasing teams still wrestle with the same three to six core challenges when sourcing CAS 74381‑53‑6 Leuprorelin Acetate:
According to a 2025 survey by PharmaSupply Insights, **37 %** of purchasing managers reported a project delay of ≥ 4 weeks due to API supply issues. If you recognize any of these scenarios, you are not alone – and you deserve a better solution.
| Parameter | Specification |
|---|---|
| CAS No. | 74381‑53‑6 |
| Chemical Name | Leuprorelin Acetate (LHRH agonist) |
| Purity | ≥ 99.5 % (HPLC) |
| Appearance | White to off‑white powder |
| Molecular Weight | 1209.44 g·mol⁻¹ |
| Solubility | Soluble in water (≤ 5 mg mL⁻¹), pH 4‑6 |
| Storage | -20 °C, protected from light |
| Packaging | HDPE bottles (100 g‑10 kg) with nitrogen flush |
| Certificate | COA, GMP, FDA DMF, ISO 9001, RoHS |
Therapeutic Areas where Leuprorelin Acetate is a cornerstone:
Case Study 1 – Rapid Oncology Launch (USA)
A leading oncology biotech needed 5 kg of GMP‑grade Leuprorelin Acetate for a Phase III trial. Our high‑speed delivery met a 14‑day deadline, saving the client **$85 k** in storage fees and preventing a 4‑week launch delay. Purity verification (99.62 %) was accepted by FDA without additional testing.
Case Study 2 – Cost‑Effective Endometriosis Therapy (EU)
A European pharmaceutical firm switched from a high‑price Chinese supplier to Global Technology. By leveraging our OEM design, they reduced raw material cost by **15 %** and achieved a stable formulation that passed EMA stability studies for 24 months.
“Switching to Global Technology cut our API cost by 12 % and cut lead time from 45 days to 14 days. The batch release certificates were flawless – we filed with the FDA in record time.”
– Dr. Emily Hart, VP of Procurement, MedPharma Inc.
“The OEM peptide design allowed us to create a patented depot formulation that outperformed competitors in stability tests.”
– Michael Liu, Technical Director, BioGenix Ltd.
CAS-23828-06-0-Rescinnamine CAS-138831-86-4-Leuprorelin Aceclofenac CAS-153299-82-2-Alitretinoin
Certificates & Compliance (all up‑to‑date):
All batches meet ≥ 99.5 % purity by HPLC, with certificate of analysis (COA) attached to every shipment.
Yes. Our R&D team can develop custom peptide sequences, acetate or other salt forms, and tailor packaging from 100 g up to 10 kg per batch.
We provide GMP certificates, DMF copies, batch release certificates, stability data (6‑month & 12‑month), and a full audit trail compatible with FDA, EMA, and Health Canada requirements.
All shipments are packed in insulated containers with dry ice, monitored by temperature data loggers. Delivery is guaranteed within 14 days, and shipping cost is included in the quoted price.
Research grade: 0.5 g – 5 g (samples available). Commercial/ GMP grade: 100 g – 10 kg per order, with volume discounts.

Yes. We provide a **free, fully‑compliant sample** (≤ 5 g) and a 30‑day money‑back guarantee if the COA does not meet the agreed specifications.
Limited stock available – only 3 months of production capacity left for 2026. Act now to lock in the best price and free sample.
Or contact us directly: Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com
John Patel – Procurement Manager, HealthGen Labs
“The 5 g free sample arrived in 24 h, and the COA confirmed 99.61 % purity. We placed a 2 kg order immediately and saved **$14 k** on logistics thanks to the included cold‑chain service.”
Linda Chen – Technical Director, EuroPharm GmbH
“Global Technology’s OEM capability let us develop a novel depot injection that passed EMA stability for 24 months. Their GMP documentation made the regulatory filing painless.”
Mark Davis – VP of Operations, BioCure Inc.
“We switched from a high‑price Chinese supplier to Global Technology and reduced our API cost by **13 %** while cutting lead time from 35 days to 14 days. Their after‑sales support is 24/7.”
Dr. Alexei Morozov – Senior API Strategy Consultant, Global Technology Co., Ltd.
With **15 years** of experience in peptide synthesis, GMP compliance, and international supply chain optimization, Dr. Morozov has authored 30+ peer‑reviewed papers on GnRH analogues and consulted for Fortune 500 pharma firms. He holds a Ph.D. in Pharmaceutical Chemistry (University of Zurich) and is a certified ISO 9001 Lead Auditor.
Contact: alexei.morozov@globaltech.com